Committed change of real-time quantitative PCR to droplet digital PCR for monitoring BCR::ABL1 transcripts in tyrosine kinase inhibitor treated CML by Adcharee Kongruang, Nittaya Limsuwanachot, Sutada Magmuang, Prapatsorn Areesirisuk, Pimjai Niparuck, Teerapong Siriboonpiputtana, Budsaba Rerkamnuaychoke

Get full text

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome by Pimjai Niparuck, Pornnapa Police, Phichchapha Noikongdee, Kanchana Siriputtanapong, Nittaya Limsuwanachot, Budsaba Rerkamnuaychoke, Suporn Chuncharunee, Teerapong Siriboonpiputtana

Get full text

A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia by Nittaya Limsuwanachot, Budsaba Rerkamnuaychoke, Pimjai Niparuck, Roongrudee Singdong, Adcharee Kongruang, Piyapha Hirunpatrawong, Thanaporn Siriyakorn, Pa-thai Yenchitsomanus, Teerapong Siriboonpiputtana

Get full text

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia by Pimjai Niparuck, Nittaya Limsuwanachot, Sulada Pukiat, Pichika Chantrathammachart, Budsaba Rerkamnuaychoke, Sutada Magmuang, Sithakom Phusanti, Kochawan Boonyawat, Teeraya Puavilai, Pantep Angchaisuksiri, Artit Ungkanont, Suporn Chuncharunee

Get full text